GlaxoSmithKline's cancer therapy cuts risk of disease progression or death by 38%

GlaxoSmithKline plc said on Monday its maintenance therapy for a form of ovarian cancer reduced the risk of disease progression or death by 38% in a late-stage study in cancer patients.


from Reuters: Health News https://ift.tt/2nP9nIE

Comentarii

Postări populare de pe acest blog

The daily coronavirus update: Double-digit deaths for second day in a row; 82,716 total cases

The Best Food, Drink, and Home Service Subscriptions to Give as Wedding Gifts

6 Easy Mother’s Day Gifts for the Mom Who Says She Doesn’t Want Anything